Recent Patents on Anti-Cancer Drug Discovery
Volume 17, 4 Issues, 2022
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access
Contents
Recent Patents on Anti-Cancer Drug Discovery , Volume 13 - Number 1
Biography
Meet Our Editorial Board Member
, 13(1): 1Vasso Apostolopoulos
DOI: 10.2174/157489281301180110155736
Review Article
Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy
, 13(1): 2 - 17Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*
DOI: 10.2174/1574892812666171030163804
Review Article
Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage
, 13(1): 18 - 39So-Yeon Park, Ji-Young Kim, Youngsoo Jun and Jeong-Seok Nam*
DOI: 10.2174/1574892812666171003150410
Review Article
Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature
, 13(1): 40 - 69Joana B. Sousa, Paula Fresco, Carmen Diniz* and Jorge Goncalves
DOI: 10.2174/1574892812666171108115959
Review Article
Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches
, 13(1): 70 - 85Viral Shah* and Pratiksha Kochar
DOI: 10.2174/1574892812666171129142023
Review Article
Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy
, 13(1): 86 - 105Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*
DOI: 10.2174/1574892812666171108124218
Review Article
NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents
, 13(1): 106 - 117Spandana R. Kopalli , Tae-Bong Kang , Kwang-Ho Lee and Sushruta Koppula*
DOI: 10.2174/1574892812666171027102627
Research Article
The Epithelial-Mesenchymal Transition Pathway in Two Cases with Gastric Metastasis Originating from Breast Carcinoma, One with a Metachronous Primary Gastric Cancer
, 13(1): 118 - 124Simona Gurzu*, Laura Banias*, Tivadar Bara, Feher I, Tivadar Jr. Bara and Ioan Jung
DOI: 10.2174/2212798409666171101121108
Patent Selections
Editor-in-Chief
Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)
Biography
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
Biography
Biography of Zhe-Sheng (Jason) Chen
Dr. Chen obtained a doctorate (Ph.D.) in Pharmacology from the Kagoshima University, Japan. He
also holds an MD degree from Guangdong Medical and Pharmaceutical College and a Master's
degree in Toxicology from Sun Yat-Sen University, China. Currently, Dr. Chen is a Professor at St.
John’s University College of Pharmacy and Health Sciences. He is also a director of the Institute for
Biotechnology at St. John’s University. He has published ~340 scientific publications including
Chemical Society of Review, Molecular Cancer, Drug Resistance Updates, Cancer Research, and
Journal Biological Chemistry etc. Besides, he is the founding Editor in Chief of the Journal of Cancer
Research Updates, an Editor-in-Chief of the Journal of New Developments in Chemistry, an editor of
Bosnian Journal of Basic Medical Sciences and an associate editor of European Journal of
Gynaecological Oncology, Frontiers in Cell and Developmental Biology, Frontiers in Oncology and
Frontiers in Pharmacology. He is also an editorial board member of 29 journals and a reviewer of
more than 270 peer-reviewed journals.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Webmaster Contact: info@benthamscience.net